Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
148 |
|
Actual shortage: | 3 (2%) | |
Anticipated shortage: | 2 (1%) | |
Avoided shortage: | 4 (3%) | |
Resolved: | 139 (94%) | |
Discontinuation Reports |
51 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 51 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
34 (17%) |
|
Overdue reports |
1 (20%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TRILEPTAL 300 MG | 300MG | TABLET | Resolved | 2020-11-09 | 2020-12-04 | 128180 |
TRILEPTAL 300 MG | 300MG | TABLET | Resolved | 2022-11-22 | 2023-04-13 | 175426 |
TRILEPTAL 600 MG | 600MG | TABLET | Resolved | 2020-11-09 | 2020-11-20 | 128183 |
TRILEPTAL 600 MG | 600MG | TABLET | Resolved | 2022-11-22 | 2023-04-13 | 175429 |
DIOVAN 80MG TABLETS | 80MG | TABLET | Resolved | 2019-12-16 | 2020-03-27 | 101436 |
DIOVAN 160MG TABLETS | 160MG | TABLET | Resolved | 2020-01-13 | 2020-03-20 | 103181 |
VIGAMOX | 0.5% | SOLUTION | Resolved | 2019-01-16 | 2019-03-26 | 72680 |
XOLAIR | 150MG | POWDER FOR SOLUTION | Resolved | 2023-11-22 | 2024-04-10 | 211221 |
DIOVAN | 40MG | TABLET | Resolved | 2020-03-09 | 2020-04-17 | 108259 |
DIOVAN | 40MG | TABLET | Resolved | 2020-04-22 | 2020-05-21 | 112812 |
DUOTRAV PQ | 0.5% 0.004% | SOLUTION | Resolved | 2018-02-01 | 2018-02-28 | 38072 |
DUOTRAV PQ | 0.5% 0.004% | SOLUTION | Resolved | 2019-11-15 | 2020-01-06 | 98922 |
DUOTRAV PQ | 0.5% 0.004% | SOLUTION | Resolved | 2020-01-13 | 2020-02-26 | 103178 |
DIOVAN | 320MG | TABLET | Resolved | 2020-04-22 | 2020-05-05 | 112809 |
TEGRETOL | 200MG | TABLET | Resolved | 2019-03-20 | 2019-07-23 | 79017 |
TEGRETOL | 200MG | TABLET | Resolved | 2019-11-08 | 2019-12-19 | 98249 |
TEGRETOL | 200MG | TABLET | Resolved | 2019-12-19 | 2020-04-17 | 101771 |
NEVANAC | 0.1% | SUSPENSION | Resolved | 2018-03-26 | 2018-04-13 | 44006 |
NEVANAC | 0.1% | SUSPENSION | Resolved | 2018-04-27 | 2018-05-25 | 47334 |
NEVANAC | 0.1% | SUSPENSION | Resolved | 2018-07-05 | 2018-07-21 | 54449 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ONBREZ BREEZHALER | 75MCG | CAPSULE | Discontinued | 2022-06-29 | 2022-07-14 | 163682 |
ZOFRAN | 4MG | SOLUTION | Discontinued | 2022-06-29 | 2022-10-18 | 163685 |
BETOPTIC S | 0.25% | SUSPENSION | Discontinued | 2022-09-28 | 2023-01-19 | 170389 |
FORADIL DRY POWDER CAPSULES FOR INHALATION | 12MCG | CAPSULE | Discontinued | 2022-10-18 | 2023-01-25 | 172087 |
ZOFRAN | 4MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189513 |
ZOFRAN | 8MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189538 |
LIORESAL INTRATHECAL 2MG/ML | 2MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201573 |
LIORESAL INTRATHECAL 0.05MG/ML | 0.05MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201576 |
LIORESAL INTRATHECAL 0.5MG/ML | 0.5MG | SOLUTION | Discontinued | 2023-08-17 | 2023-09-19 | 202298 |
TASIGNA | 50MG | CAPSULE | Discontinued | 2023-10-19 | 2023-11-06 | 207564 |
SANDOSTATIN | 100MCG | SOLUTION | Discontinued | 2024-03-22 | 2024-03-22 | 223070 |